Comparison of 18F-Fluciclovine PET versus 18F-FluoroethyltyrosinePET in patients with newly diagnosed cerebral gliomas, recurrentcerebral gliomas and brain metastases – an open label single centresingle arm prospective basket trial - 23-096

niversitaetsklinikum Aachen AöR0 个研究点目标入组 240 人开始时间: 2023年12月15日最近更新: 2024年8月21日

适应症

试验速览

暂无简介。

•Patient is = 18 years old., Patient is mentally and physically able to understand the significance and scope of the study and to comply with the study staff., Patient has decision-making capacity: capable of giving consent, insight, and information., Patient has signed a written informed consent form prior to participation in the study., Patient is referred to the Nuclear Medicine Clinic of the University Hospital Aachen for FET PET of the brain based on the prescription of the treating physicians., Patient has suspected glioma prior to biopsy or surgery. OR, Patient has suspected tumour recurrence after previous treatment for cerebral glioma or brain metastasis.

•Patient is pregnant or breastfeeding., Patient is not willing to take adequately safe contraceptive measures., Patient is institutionalised due to official or court order., Patient is in a dependent relationship or employment relationship with the sponsor, investigator or his or her deputy., Patient has insufficiently controlled epilepsy., Patient is unable to lie still for 40 minutes.

发起方

niversitaetsklinikum Aachen AöR